Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a sleep drug fix lingering insomnia in depression? new study seeks answers.

NCT ID NCT06843187

First seen May 15, 2026 · Last updated May 20, 2026 · Updated 1 time

Summary

This study tests whether Lemborexant, a sleep medication, can help adults with treated depression who still struggle with insomnia. About 30 participants will take either the drug or a placebo daily for 6 weeks, tracking sleep and symptoms. The goal is to see if the drug is practical, tolerable, and effective for improving sleep.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • St. Michael's Hospital, Unity Health Toronto

    RECRUITING

    Toronto, Ontario, M5B 1W8, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.